News

Articles
UCLA Health benefits patient care through technology, earns seventh consecutive "Most Wired" designation
09/19/2019
For the seventh consecutive year, UCLA Health placed among the nation's leaders in utilizing technology to improve the quality of patient care. UCLA Health earned a "Most Wired" performance excellence award in 2019 surveys of both inpatient and ambulatory settings conducted by the College of Healthcare Information Management Executives (CHIME).

Articles
UCLA oncologist Dennis Slamon wins 2019 Lasker Award for clinical medical research
09/10/2019
Physician-scientist Dr. Dennis Slamon, professor and chief of hematology/oncology at the David Geffen School of Medicine at UCLA, has been awarded the 2019 Lasker-DeBakey Clinical Medical Research Award for the groundbreaking development of breast cancer drug Herceptin (trastuzumab), a lifesaving therapy for women with HER2-positive breast cancer.

Articles
Artificial intelligence could yield more accurate breast cancer diagnoses
09/04/2019
UCLA researchers have developed an artificial intelligence system that could help pathologists read biopsies more accurately and to better detect and diagnose breast cancer. The new system, described in a study published today in JAMA Network Open, helps interpret medical images used to diagnose breast cancer that can be difficult for the human eye to classify, and it does so nearly as accurately or better as experienced pathologists.

Articles
Treating stroke patients just 15 minutes earlier can save lives
08/20/2019
Initiating stroke treatment just 15 minutes faster can save lives and prevent disability, according to a new UCLA-led study, published today in JAMA. The research also determined that busier hospitals — those that treat more than 450 people for stroke each year — have better outcomes than those that treat fewer than 400 stroke patients per year.

Articles
Antibiotics before liver transplants lead to better results
08/08/2019
A UCLA-led research team has found that giving mice antibiotics for 10 days prior to a liver transplant leads to better liver function after the surgery. After concluding the experiment mice, the scientists discovered data from liver transplants performed between October 2013 and August 2015 at the Ronald Reagan UCLA Medical Center, revealing that the same phenomenon appears to hold true in humans.

Articles
UCLA Health hospitals rank #1 in L.A. and California, #6 in nation
07/30/2019
U.S. News & World Report released its Best Hospitals rankings for 2019-20 on July 30. To compile the 30th annual ranking, U.S. News compared more than 4,500 hospitals nationwide across 16 specialties and nine procedures and conditions. And for the 30th consecutive year, U.S. News & World Report places UCLA on national honor roll reserved for top medical centers.

Articles
UCLA Mattel Children’s Hospital recognized among best children’s hospitals in U.S.
07/17/2019
U.S. News & World Report has recognized UCLA Mattel Children's Hospital for excellence across all pediatric specialties in its 2019-20 Best Children's Hospitals rankings. In three pediatric specialties — gastroenterology and gastrointestinal surgery nephrology; and orthopaedics — UCLA Mattel Children's Hospital placed among the top 20 children's hospitals nationally. In the seven other specialties assessed in the annual rankings — cancer; cardiology and heart surgery; diabetes and endocrinology; neonatology; neurology and neurosurgery; pulmonology and lung surgery; and urology — the hospital ranked among the top 50.

Articles
Nerve stimulation could provide new treatment option for most common type of stroke
06/28/2019
Research led by a UCLA scientist found that a new nerve stimulation therapy to increase blood flow could help patients with the most common type of stroke up to 24 hours after onset. A study of 1,000 patients found evidence that the technique, called active nerve cell cluster stimulation, reduced the patients' degree of disability three months after they suffered an acute cortical ischemic stroke, which affects the surface of the brain.

Articles
Immunotherapy improves five-year survival rate of people with advanced lung cancer
06/21/2019
In a study led by UCLA investigators, treatment with the immunotherapy drug pembrolizumab helped more than 15% of people with advanced non-small cell lung cancer live for at least five years — and 25% of patients whose tumor cells had a specific protein lived at least that long. When the study began in 2012, the average five-year survival rate was just 5.5% for people with that type of cancer.

Articles
On-site 3D printing helps physicians prepare for complex surgeries
06/14/2019
Heart surgeons and interventional congenital and structural cardiologists at UCLA Health are using 3D printed models of patients’ hearts to ensure the best surgical outcomes. “The models provide a more detailed look at a patient’s unique heart anatomy and help us in the presurgical planning stages, so we know what adjustments to make before we go into the catheterization lab or operating room,” says Sanjay Sinha, MD, an interventional pediatric cardiologist at UCLA Mattel Children’s Hospital.